31.6 C
Dubai

“NHS Blood Test Initiative Uncovers Thousands of Undiagnosed Hepatitis Cases”

Must read

A recent initiative by the NHS to conduct routine blood tests on individuals visiting emergency departments has uncovered thousands of undiagnosed cases of hepatitis B and C, conditions that can progress to liver cirrhosis. The UK Health Security Association released findings from its bloodborne virus testing program across 34 A&E units located in regions with high HIV prevalence, aligning with the government’s target to eliminate new HIV transmissions by 2030. Out of every 2,000 people screened, half were in the advanced stages of HIV.

Public Health Minister Ashley Dalton expressed satisfaction with the program’s success in identifying otherwise missed infections and promptly connecting patients to life-saving interventions. This approach not only facilitates early treatment but also aids in protecting the broader community and advancing the goal of ending new HIV transmissions by the next decade. HIV, a virus that weakens the immune system and may progress to AIDS without intervention, currently lacks a definitive cure, but proper medical management can effectively control it.

Hepatitis, a disease affecting the liver and potentially leading to cirrhosis or liver cancer, was detected in one out of 240 individuals for hepatitis B and one out of 1,276 for hepatitis C. The bloodborne virus program mandated HIV, hepatitis B, and hepatitis C testing for A&E patients unless they chose to opt out, with a 70% acceptance rate from eligible subjects.

Dr. Claire Fuller, NHS England’s medical director, emphasized the instrumental role of blood-borne virus testing in emergency departments in early detection and treatment of HIV and viral hepatitis, improving prospects for thousands in accessing life-saving therapies and reducing transmission risks. Dr. Sema Mandal, Consultant Epidemiologist and deputy director at the UKHSA, lauded the opt-out testing strategy for identifying numerous cases of undiagnosed HIV, hepatitis B, and hepatitis C, stressing the importance of heightened awareness, expanded testing, and robust support systems for affected individuals to prevent severe health consequences and save lives.

More articles

Latest article